Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II study of HRS-6719 in MTAP-deleted advanced solid tumors
CTR20251283Phase 2Active
- Sponsor
- Shandong Sende
- Start
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ASP8731 in Nonhematologic neoplasms, sponsored by Shandong Sende. Started Apr 2025; status: active.
02
Drugs
ASP8731
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20251283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20251283.